EAN Congress news

Interview with Frank Winkler, who delivered the Brain Prize Lecture during the Opening Session of the 12th Congress of the European Academy of Neurology.

Migraine is a major focus of current neurological practice, with several new guideline recommendations highlighting migraine‑specific treatments. This growing interest was reflected in a packed room at EAN 2026.

This session brought together global, European, and national perspectives to discuss an urgent question: how can we move from recognising the burden of neurological disorders to acting on it more effectively?

This session changed the way participants will approach a febrile neurological presentation. The mosquito is now a neurologist's problem, and the time to update our thinking is now.

The second day of the EAN Congress 2026 closed with a session that was both scientifically rich and clinically important, hosted in collaboration with the European Society of Cardiology.

The EAN Congress 2026 Presidential Symposium in Geneva offered a compelling snapshot of modern neurology in motion – a field increasingly defined by its ability to turn scientific discovery into tangible benefits for patients.

This session introduced The Michael J. Fox Foundation (MJFF), a US-based non-profit that has funded Parkinson's disease (PD) research since 2000.

This EAN TV session, in cooperation with EFNA, set the spotlight on the patient’s perspective in rare neurological diseases.

On Sunday afternoon, the annual EAN BrainChallenge quiz brought a challenging and educational competition to the Main Auditorium at the EAN Congress 2026.

The EAN Congress 2026 opened with a clear message: the future of neurology will be shaped not by individual efforts alone, but by a community working together across borders, disciplines and generations.

This session offered a fascinating overview of both invasive and non-invasive neuromodulation for movement disorders, featuring a distinguished panel of speakers.

The EAN 2026 Opening Session took place in the Main Auditorium of the Palexpo, Geneva, on Saturday night, with the whole show streamed live on the EAN Congress website.

As the therapeutic landscape has changed rapidly in recent years, this update on the expanding range of options for the treatment of myasthenia gravis was highly welcome.

This EAN TV session highlighted the importance of coordinated action, policy dialogue, and collaboration for neurological health and brain health across Europe.

This packed session at EAN 2026 was co-organised by the EAN and Neurotorium.org a free brain awareness and educational website founded by the Lundbeck Foundation.